- Gilead Sciences
This is our global website, intended for visitors seeking information on Gilead’s worldwide business Some content on this site is not intended for people outside the United States
- Gilead Sciences: Company
Learn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information
- Gilead Sciences – Leading with world-class science
Fueled by scientific innovation, we’re generating transformative medicines and cures across virology, oncology and inflammation
- Newsroom | Gilead
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial November 7, 2025
- Pursuing Advances in Research at Gilead Sciences
For more than 35 years, our scientific insights and bold ambitions for transforming the course of disease have guided Gilead researchers to achieve advancements in drug discovery that were once thought impossible – including cures
- Careers at Gilead Sciences
Gilead, a global biopharma co pursuing innovation in virology, oncology and inflammation, offers a variety of career opportunities in an inclusive workplace where all can make an impact
- ギリアド・サイエンシズについて | Gilead
グラントウキョウサウスタワー16F 設立: 2012年11月 代表者: 代表取締役社長ケネット・ブライスティング 従業員数: 799名（2024年7月現在） 事業内容: 医療用医薬品、再生医療等製品の製造・販売など URL: www gilead com ja-jp
- Gilead Sciences, Inc. - Stock Information
IR Contact Gilead Investor Relations (650) 574-3000 investor_relations@gilead com Follow Us Investor Email Alerts News Quarterly Reports SEC Filings End of Day Stock Quote Events Presentations
|